[Tocolytic substituent treatment with Magnerot in threatened abortions and premature labor from the 16th to the 36th gestational week].
The Mg's low level in the sera and the urine correlate with clinical symptoms of uterine contraction in pregnant women from the 16th-36th gestation week. The authors present their experience with the use of removal tocolytic curing with Magnerot tabl. in the cases of 60 pregnant women with uterine pain and contractions from 16th to 36th gestation week and Pelvic Score after Bishop under 4. The effect of the curing is remarkable till from the beginning in the first 4-7 days of it, which is demonstrated with disappearing of the objective and subjective contractions (overviewed in obstetric monitor) and there is normalising of the paraclinical levels of the Mg in the sera and the urine, with normal pregnancy and birth of a healthy and alive child.
Damianov
L
L
Negentsov
N
N
Ivanov
S
S
Novachkov
V
V
Tsachev
K
K
D000033:Abortion, Threatened / Q000188:drug therapy* / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008274:Magnesium / Q000378:metabolism / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000188:drug therapy* / Q000378:metabolism; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D013607:Tablets; D013997:Time Factors; D015149:Tocolytic Agents / Q000627:therapeutic use*
D013607:Tablets; D015149:Tocolytic Agents; D008274:Magnesium
Tokolitichno zamestitelno lechenie s Magnerot pri zaplashvashti aborti i prezhdevremenni razhdaniia ot 16-ta do 36-ta gestatsionna sedmitsa.